In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cortecs Ltd.

Division of Galen Ltd.

Latest From Cortecs Ltd.

Neurotech SA

Neurotech is making use of the angiogenic properties of tumors to eradicate them. Beyond brain tumors, Neurotech is targeting other conditions where angiogenesis is important, for example, ischemic stroke. Neuortech's approach is also suited to a variety of other neurological disorders, including Alzheimer's disease and Parkinson's disease.
BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Galen Ltd.
  • Senior Management
  • Michael Flynn, PhD, CEO
    Peter Newcomb, CFO
    Keith King, Marketing/Sales
    Michael Story, PhD, Research & Development
  • Contact Info
  • Cortecs Ltd.
    Phone: (44) 81 568 7071
    The Old Blue School
    Lower Square
    Isleworth, TW7 6RL
    UK
UsernamePublicRestriction

Register